Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2010
07/07/2010EP2204183A1 Treatment of neuroblastoma
07/07/2010EP2204182A1 Non-cytotoxic protein conjugates
07/07/2010EP2204181A2 Protease inhibitors
07/07/2010EP2203558A2 Translocation and mutant ros kinase in human non-small cell lung carcinoma
07/07/2010EP2203476A2 Compositions and methods for inhibiting interleukin pathways
07/07/2010EP2203473A1 Sdf-1-based glycosaminoglycan antagonists and methods of using same
07/07/2010EP2203181A2 An orally administerable solid pharmaceutical composition and a process thereof
07/07/2010EP2203180A1 Single ifn-beta fused to a mutated igg fc fragment
07/07/2010EP2203179A1 Vancomycin and teicoplanin anhydrous formulations for topical use
07/07/2010EP2203173A2 Means and methods for counteracting muscle disorders
07/07/2010EP2203159A1 Dispersion of poloxamer- protein particles, methods of manufacturing and uses thereof
07/07/2010EP2203155A1 Treatment of pulmonary disorders with aerosolized medicaments such as vancomycin
07/07/2010EP1682178B1 Methods of therapy for cancers expressing the cd40 antigen
07/07/2010EP1622568B1 Interleukin-9 antagonist muteins and their pharmacological methods of use
07/07/2010EP1545595B1 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
07/07/2010EP1507866B1 Carotene synthase gene and uses therefor
07/07/2010EP1499888B1 Conformationally constrained peptides that bind the orl-1 receptor
07/07/2010EP1470218B1 Corona-virus-like particles comprising functionally deleted genomes
07/07/2010EP1448594B1 A food grade lantibiotic from streptococcus macedonicus and uses thereof
07/07/2010EP1446158B1 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including cd4
07/07/2010EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
07/07/2010EP1079862B1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
07/07/2010EP0979284B2 Reagents for vaccination which generate a cd8 t cell immune response
07/07/2010CN1850976B Glucose kinase derivant and its preparing method
07/07/2010CN1778816B Human cell surface membrane molecule and use thereof
07/07/2010CN101772513A Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
07/07/2010CN101772512A Targeted induction of aggregation of proteins with cross beta structures
07/07/2010CN101772507A proteasome inhibitors
07/07/2010CN101772351A A novel bone mass increasing agent
07/07/2010CN101772350A Fibrin gel for controlled release of PDGF and uses thereof
07/07/2010CN101768580A Novel fibrinolysin and preparation method and use thereof
07/07/2010CN101768578A Eosinophilic lactase BGALA, gene and application thereof
07/07/2010CN101768219A Recombinant fusion protein and preparing method and application thereof
07/07/2010CN101768215A House lizard glycopeptide, method for preparing same and medicinal application thereof
07/07/2010CN101768211A HN protein and F protein of newcastle disease virus Italien strain and application thereof in gene therapy medicament
07/07/2010CN101768209A Hypotensive peptide with high in-vivo activity and preparation and purification method thereof
07/07/2010CN101766813A Suppository for treating mammalian endometritis and preparation method thereof
07/07/2010CN101766812A Liquid drug combination containing exenatide or analogues thereof
07/07/2010CN101766811A Application of exenatide acetate or analogue thereof in preparing drug for treating or preventing diabetes complicated with cerebral infarction
07/07/2010CN101766810A Medical preparation containing recombinant human granulocytecolony stimulating factor
07/07/2010CN101766809A Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure
07/07/2010CN101766808A Method for obtaining series analgesic active peptides DKK and analogs thereof and application of series analgesic active peptide DKK and analogs thereof
07/07/2010CN101766807A Injection packaging preparation of thymosin pha1 microspheres
07/07/2010CN101766806A Application of CRISPLD2 protein in aspect of inflammation
07/07/2010CN101766805A Stabilized antibacterial peptide preparation and preparation method thereof
07/07/2010CN101766228A Iimmune stimulatory infant nutrition
07/07/2010CN101338284B Degradation strain capable of high-efficiency degrading bactericide chlorothalonil and use thereof
07/07/2010CN101182360B Fusion protein having antibiotic function and uses thereof
07/07/2010CN101032532B Medicine composition including active substrates extracted from Sang Huang, the preparing method and the application in the producing of medicine thereof
07/07/2010CN101002930B Medicine composition containing aniracetam and brain protein hydrolyte
07/06/2010US7750204 Methods for producing antibody
07/06/2010US7750143 Short interference ribonuclic acids for treatment and prevention of diabetic retinopathy, age related macular degeneration and cancer; gene expression inhibition
07/06/2010US7750141 Modified oligonucleotides for treatment and prevention of hypertriglyceridemia; gene expression inhibition
07/06/2010US7750138 consisting of different fragments of the VEGF receptors FLT-1 and KDR and human immunoglobulin Fc; treatment of angiogenesis-related diseases including tumor, diabetic retinopathies, arthritis, anemia and endometrial hyperplasia; vectors; host cell
07/06/2010US7750137 Comprises nucleotide sequences coding mucosal addressin cell adhesion molecule-1 (madcam-1) for diagnosis and treatment of inflammatory bowel disease and gastorintestinal disorders
07/06/2010US7750136 Using ribosome-inactivating protein (RIP)/cytotoxin fusion to target and destroy tumor cells
07/06/2010US7750133 Vascular endothelial cell growth inhibitor, VEGI-192a
07/06/2010US7750128 Modified Fc molecules
07/06/2010US7750127 Modified Fc molecules
07/06/2010US7750126 Antibodies that bind to a member of the IL-6/G-CSF/MGF family
07/06/2010US7750125 C35 tumor antigen specific monoclonal for use in diagnosis, prevention and treatment of cell proliferative disorders
07/06/2010US7750121 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents
07/06/2010US7750120 Enhanced nenbrane binding affinity; blood coagulation
07/06/2010US7750118 Apo-2 receptor polypeptides
07/06/2010US7750117 Mixing protein with a saccharide compound in a liquid suspension and then drying to produce a solid that contains the protein and the saccharide
07/06/2010US7750115 Epithelial cell growth promoter
07/06/2010US7750114 Peptides having a high cysteine content
07/06/2010US7750050 Enhancing activity of an acid sphingomyelinase (ASM) protein with an analogue of ceramide, sphingomyelin or phosphonucleotide; gene therapy
07/06/2010US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
07/06/2010US7749984 drug design, a derivative of dextromethorphan having an imidazolidine group; calcium channel blockers
07/06/2010US7749971 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy
07/06/2010US7749970 Application of an azalide antibiotic such as azithromycin
07/06/2010US7749969 N- or C- terminally modified small peptides
07/06/2010US7749968 Peptides for targeting the prostate specific membrane antigen
07/06/2010US7749967 immunogenic peptides of a melanoma antigen recognized by T cells, designated gp100; peptide being reactive with T cells or inducing an immune response; anticarcinogenic agents
07/06/2010US7749966 Compositioncomprising somatomedin polypeptide for use in generating immunoglobulins which bind, inactivate or suppress activity from insulin-like growth factor 1 receptor; antitumor agents; immunotherapy
07/06/2010US7749965 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
07/06/2010US7749964 treating osteoarthritis with OSTEOCHONDRAL GRAFTS consisting of ACTIVE GROWTH FACTORBONE MORPHOGENETIC PROTEIN
07/06/2010US7749963 Isolated recombinant vaccinia virus complement control protein (hrVCP) polypeptide
07/06/2010US7749962 administering to mammal with breast cancer as adjuvant therapy an agent effective in blocking interaction of integrin with extracellular matrix protein of bone marrow microenvironment or that downregulates expression of integrin; integrin is alpha 5 beta 1 and extracellular matrix protein is fibronectin
07/06/2010US7749961 Macrocyclic peptides active against the hepatitis C virus
07/06/2010US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function
07/06/2010US7749959 Use of HMGB fragments as anti-inflammatory agents
07/06/2010US7749958 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents
07/06/2010US7749957 Clay-binding peptides and methods of use
07/06/2010US7749956 Method of treatment using adiponectin variants
07/06/2010US7749955 separating two forms of a polypeptide having a single amino acid racemization by eluting the two forms of the polypeptide from an ion exchange chromatography resin under conditions where the salt concentration is increased at a pH that is no more than 1 pH unit from a pKa of X
07/06/2010US7749954 Use of calcitonin in osteoarthritis
07/06/2010US7749953 comprising regulating the expression or activity of cannabinoid receptors in bone cells
07/06/2010US7749758 Human and mammalian stem cell-derived neuron survival factors
07/06/2010US7749757 Using lysine, glycine and formaldehyde fixative as tool to preserve cells, cell components, antigenic sites, light scatter properties and cellular morphology of tissues
07/06/2010US7749752 Using vector comprisng nucleotide sequences coding cell binding elements to transform cells and identify lymphocyte response modulators
07/06/2010US7749742 Method for producing tripeptides and/or peptides longer than tripeptides
07/06/2010US7749735 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta
07/06/2010US7749719 bioassay to detect diagnosis of skin cancer; isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; immunogen or vaccine for cancer prevention and treatment; immunotherapy
07/06/2010US7749718 Method for raising or isolating an antibody to DCRS5
07/06/2010US7749715 TCL-1 gene and protein and related methods and compositions
07/06/2010US7749695 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders
07/06/2010US7749694 Providing class of binding proteins with a range of binding specificities and affinities based upon variation at select amino acid positions within a scaffold; no conformational shifts in the hemagglutinin folds
07/06/2010US7749543 Methods useful in the treatment of bone resorption diseases
1 ... 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 ... 3163